Category Archives: Pr Newswire

Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr

WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced the successful dosing of the first patient in its open-label Phase 1 imaging and dosimetry clinical trial of its uPAR-targeted imaging radiopharmaceutical MNPR-101-Zr. MNPR-101-Zr was well-tolerated with no […]

IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update

Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immuno-oncology therapy, today reported financial results for the three and six months ended June 30, 2024. The Company also provided an update on its clinical […]

VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Initiated Phase 2b trial of VYN201 in nonsegmental vitiligo, with top-line results expected in mid-2025 Phase 1a SAD/MAD trial of VYN202 progressing, with data from the SAD and MAD portions expected in Q3 and Q4 2024, respectively Balance sheet expected to fund key clinical milestones for VYN201 and VYN202 through the end of 2025 BRIDGEWATER, […]

Four Seasons Education Announces Cash Dividend

SHANGHAI, Aug. 14, 2024 /PRNewswire/ — Four Seasons Education (Cayman) Inc. (“Four Seasons Education” or the “Company”) (NYSE: FEDU), a tourism and education-related service provider in China, today announced that its Board of Directors has declared a cash dividend of US$0.23 per ordinary share, or US$2.30 per American Depositary Share (“ADS”). The dividend is expected […]

NEOM McLaren Extreme E Joins Vantage Markets to Ignite “Reborn” Phase of the “Reborn a Trader” Campaign

LONDON, Aug. 14, 2024 /PRNewswire/ — Multi-asset broker Vantage Markets (“Vantage”) is proud to announce the “Reborn” phase of its “Reborn a Trader” campaign in collaboration with the NEOM McLaren Extreme E team. This latest collaboration features two exclusive interviews with NEOM McLaren Extreme E drivers, Mattias Ekström and Cristina Gutierrez, who share their personal […]

The Grand Opening of AIMA’s First Flagship Store on Lombok Island Marks Another Key Step in Its Global Expansion

MATARAM, Indonesia, Aug. 14, 2024 /PRNewswire/ — On August 12, AIMA, a leading brand in the electric two-wheeler industry, celebrated the grand opening of its first flagship store on Lombok Island, Indonesia. The event was attended by notable guests, including Ma Faming, General Manager of PT AIMA Electric Vehicles Indonesia, Li Shouchen, General Manager of […]

Yannick Fierling appointed as new President and CEO of Electrolux Group

STOCKHOLM, Aug. 14, 2024 /PRNewswire/ — The Board of Directors of AB Electrolux has appointed Yannick Fierling as new President and CEO of Electrolux Group effective January 1, 2025. Yannick Fierling succeeds Jonas Samuelson, who earlier this year informed the Board that he will leave his position by the end of the year. Yannick Fierling has more […]

TENCENT ANNOUNCES 2024 SECOND QUARTER RESULTS

HONG KONG, Aug. 14, 2024 /PRNewswire/ — Tencent Holdings Limited (HKEX: 00700 (HKD Counter) and 80700 (RMB Counter), “Tencent” or the “Company”), a world-leading Internet and technology company in China, today announced the unaudited consolidated results for the second quarter (“2Q2024”) ended Jun 30, 2024. Mr. Ma Huateng, Chairman and CEO of Tencent, said, “Our […]

HealthEquity Sets Date to Announce Second Quarter Results Presentation at Conferences

DRAPER, Utah, Aug. 13, 2024 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA”) custodian, today announced plans to release its second quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Tuesday, September 3, 2024. Following the news release, […]

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Launched Nova Cell subsidiary with $2 million investment from Dr. Ronald Rigor to advance Calidi’s Adult Adipose Allogeneic (AAA) stem cell innovative programs Strengthened team with the appointment of Dr. George E. Peoples, MD, FACS, adjunct professor of Surgical Oncology at MD Anderson Cancer Center, to the company’s Board of Directors, and the addition of […]